- This event has passed.
Exercise in place: Part 3 – Fall Prevention and Response
August 4, 2020 @ 6:00 pm - 7:30 pm EDTFree
Register to join us for
Exercise in Place: Part 3 – Fall Prevention and Response, with Megan, Lauren, Fin, and Ruben, part of the PT/OT team at Johns Hopkins Myositis Center
Tuesday, August 4, 2020, at 6:00 PM Eastern Time
Join MSU along with occupational therapists Megan McGowan and Lauren Burgess, and physical therapists Fin Mears and Ruben Pagkatipunan, with the Johns Hopkins Myositis Center for Part 3 of our Exercise in Place webinar series.
Part 3 will focus solely on falls, including fall prevention and response.
Did you miss Exercise in Place Part 1 and 2?
Exercise in Place is a very popular series! Watch the previously recorded sessions for:
- answers to questions submitted directly by you, myositis patients;
- helpful information for myositis patients to Exercise in Place while we shelter in place, and after;
- exercise demonstrations with tips and modifications to exercise with and without equipment;
- information about occupational and physical therapy for myositis patients;
- and so much more!
About joining this webinar
REGISTRATION IS REQUIRED for this free webinar. Click the Register button above to get started. After registration, you will receive an email containing all of the information you need to join the webinar on the scheduled time and date. Be sure to check your spam and junk folders if you do not see the email.
Joining us from the Johns Hopkins Myositis Center
Megan McGowan, Occupational Therapy
Megan McGowan received her M.S. in occupational therapy from Keuka College of Keuka Park, NY in 2012. Megan has been practicing at Johns Hopkins Bayview Medical Center for 5 years. Her clinical focus has been within acute care and within the Johns Hopkins Myositis Clinic. Megan has a clinical specialty in myositis and has been working in the clinic for 4 years. She has presented nationally at The Myositis Association conference and has held an active role in research studies being performed within the Johns Hopkins Myositis Clinic.
Lauren Burgess, Occupational Therapy
Lauren Burgess received her master’s degree in occupational therapy in 2015 at the University of Southern California. At Johns Hopkins Bayview Medical Center she practices in the acute care setting, working with a variety of patient populations. She is also one of two primary occupational therapists for the Johns Hopkins Myositis clinic, where she works collaboratively with other providers to offer a patient-centered, multi-disciplinary approach to care.
Fin Mears, Physical Therapy
Fin Mears received his bachelor’s degree in physical therapy from the University of Maryland, Baltimore in 1990. He has been working at Johns Hopkins Bayview Medical Center since 1990. Initially hired as an acute care therapist, for the past 15 years he has been Clinical Coordinator for Rehabilitative Services and Center Coordinator for Clinical Education. Since 2014 his clinical practice has focused on inflammatory myopathies and dysautonomia. Fin Mears and Ruben Pagkatipunan are the two primary physical therapists for the Johns Hopkins Myositis Center.
Ruben Pagkatipunan Jr., Physical Therapy
Ruben Pagkatipunan Jr. received his bachelor’s degree in physical therapy at the University of Santo Tomas in Manila, Philippines in 1993. In 2016, he obtained his doctorate degree in Physical Therapy at the College of St. Scholastica in Duluth, MN. Ruben is also a board-certified orthopedic clinical specialist from the American Board of Physical Therapy Specialties since 2014. His clinical practice and primary research areas of interests include evaluation and management of patients with inflammatory myopathies and dysautonomia. He is the primary physical therapist at the Johns Hopkins Bayview Neuromuscular Rehabilitation team, the Normal Hydrocephalus clinic, and the Dysautonomia clinic. In 2017, he published an article with the Johns Hopkins Myositis Center on the role of the myositis Functional Index-2 in identifying muscle impairment in myositis patients with near-normal or normal muscle strength. Currently, he participates in clinical research on inclusion-body myositis (IBM) that investigates the effect of the diabetes drug pioglitazone in the health and function of mitochondria in skeletal muscles of IBM patients.